{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:25:18Z","timestamp":1792207518124,"version":"4.4.0"},"reference-count":98,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/17474086.2025.2570332","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:49:54Z","timestamp":1759402194000},"page":"17-31","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Novel therapeutics for immune thrombocytopenia: an evolving treatment landscape"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1641-1472","authenticated-orcid":false,"given":"Kun","family":"Huang","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang University School of Medicine","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44337-024-00008-8"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-020-01351-3"},{"issue":"4","key":"e_1_3_4_5_1","first-page":"361","article-title":"Safety and efficacy of splenectomy in immune thrombocytopenia","volume":"11","author":"Mishra K","year":"2021","unstructured":"Mishra K, Kumar S, Sandal R, et al. Safety and efficacy of splenectomy in immune thrombocytopenia. Am J Blood Res [Internet]. 2021;11(4):361\u2013372.","journal-title":"Am J Blood Res"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-020-01286-9"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2024000596"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/hematolrep16030039"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta15suppl1-03"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01209.x"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-188481"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103581"},{"key":"e_1_3_4_13_1","first-page":"1","article-title":"The function of T cells in immune thrombocytopenia","volume":"16","author":"Bu S","year":"2025","unstructured":"Bu S, Liu M, Yang L, et al. The function of T cells in immune thrombocytopenia. Front Immunol. 2025;16(February):1\u201313.","journal-title":"Front Immunol"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042163"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02504-2"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2024.2375177"},{"issue":"12","key":"e_1_3_4_17_1","first-page":"15642","article-title":"Expression of CD11a in lymphocyte subpopulation in immune thrombocytopenia","volume":"8","author":"Liu YX","year":"2015","unstructured":"Liu YX, Zhang F, Yao QM, et al. Expression of CD11a in lymphocyte subpopulation in immune thrombocytopenia. Int J Clin Exp Pathol. 2015;8(12):15642\u201315651.","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60203-2"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.4155\/cli.10.23"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-603365"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.212845"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S191790"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.05.025"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/rai2.70000"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15602"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.20100"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3892\/br.2024.1732"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206139"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14425"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281402"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27303"},{"issue":"6","key":"e_1_3_4_33_1","first-page":"259","article-title":"Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: luna 3 phase III study David","volume":"9","author":"Soiza RL","year":"2018","unstructured":"Soiza RL, Donaldson AIC, Myint PK. Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: luna 3 phase III study David. Ther Adv Vaccines. 2018;9(6):259\u2013261.","journal-title":"Ther Adv Vaccines"},{"key":"e_1_3_4_34_1","unstructured":"Kuter D. ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP. Available from: https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2024.2024;04:2\u20135"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023012044"},{"key":"e_1_3_4_36_1","unstructured":"Knobe K. Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines. 2025. Available from: https:\/\/www.sanofi.com\/assets\/dotcom\/pressreleases\/2025\/2025-04-03-05-00-00-3054815-en.pdf"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-05031-2"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2199341"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.70152"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.07.015"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1472845"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01263-7"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002003"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25680"},{"issue":"6","key":"e_1_3_4_45_1","first-page":"259","article-title":"Efgartigimod alfa for the treatment of primary immune thrombocytopenia","volume":"9","author":"Broome C","year":"2018","unstructured":"Broome C. Efgartigimod alfa for the treatment of primary immune thrombocytopenia. Ther Adv Vaccines. 2018;9(6):259\u2013261.","journal-title":"Ther Adv Vaccines"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01460-5"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01678-3"},{"key":"e_1_3_4_48_1","unstructured":"Report on the deliberation results. 2019. Available from: https:\/\/www.pmda.go.jp\/files\/000273743.pd"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27448"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2025.2497840"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01933-1"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103719"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800998"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000574"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.34133\/research.0236"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19070"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014955"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006864"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022006960"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.07.004"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308695"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09084.x"},{"key":"e_1_3_4_63_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1180509","article-title":"The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?","volume":"14","author":"Berentsen S","year":"2023","unstructured":"Berentsen S, Fattizzo B, Barcellini W. The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket? Front Immunol. 2023;14(April):1\u201314.","journal-title":"Front Immunol"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1215216"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.261099"},{"issue":"2","key":"e_1_3_4_66_1","first-page":"1","article-title":"Effects of daratumumab (anti-CD38) monoclonal antibody therapy on flow cytometry analysis in multiple myeloma","volume":"2","author":"Germans SK","year":"2025","unstructured":"Germans SK, Kahlow CW, Chen W. Effects of daratumumab (anti-CD38) monoclonal antibody therapy on flow cytometry analysis in multiple myeloma. Therapeutics. 2025;2(2):1\u201314.","journal-title":"Therapeutics"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19660"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.817762"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-023-01608-7"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-022-05035-y"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S487895"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2024.100043"},{"issue":"6","key":"e_1_3_4_73_1","first-page":"259","article-title":"Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study Roy","volume":"9","author":"Vitkon R","year":"2018","unstructured":"Vitkon R, Netanely D, Levi S, et al. Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study Roy. Ther Adv Vaccines. 2018;9(6):259\u2013261.","journal-title":"Ther Adv Vaccines"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000517"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0040-1"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284417"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16363"},{"issue":"10","key":"e_1_3_4_78_1","first-page":"2707","article-title":"Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase IIb trial","volume":"106","author":"El Hoss S","year":"2021","unstructured":"El Hoss S, Cochet S, Godard A, et al. Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase IIb trial. Haematologica. 2021;106(10):2707\u20132719.","journal-title":"Haematologica"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214720"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05306-5"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.662"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07039.x"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21601"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.630693"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111606"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013496"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279751"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.33696\/immunology.2.012"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-022-02651-3"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.3109\/09537104.2014.948838"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-657981"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106895"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26036"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26045"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285364"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024027336"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05466-1"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.568"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.5429"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26497"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2025.2570332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:53:12Z","timestamp":1767592392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2025.2570332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/17474086.2025.2570332"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2025.2570332","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}